KKR made a minority investment in Oyster Point Pharma.

Synopsis

Private equity firm KKR & Co, through its investment platform Falcon Vision, made a minority investment in Oyster Point Pharma, a clinical-stage pharmaceutical company that develops therapies to treat Dry Eye Disease. Financial terms were not disclosed.

Principals

target

Oyster Point Pharma

bidder

Kkr & Co

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (1)

jeffrey nau

President and CEO at OYSTER POINT PHARMA INC

Manager

target

Deals

£ 659 M

Total Value

Bidder Team (1)

josh dubofsky

Partner at Latham & Watkins

Lawyer

bidder

Deals

£ 182.05 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy